Research programme: anti-EGFR proteins - Med DiscoveryAlternative Names: MDP 01; p-EGF; Peptabody-EGF
Latest Information Update: 06 Oct 2010
At a glance
- Originator Med Discovery
- Class Proteins
- Mechanism of Action Epidermal growth factor inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 21 Mar 2006 Preclinical trials in Cancer in Switzerland (unspecified route)